Status:
RECRUITING
Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata
Lead Sponsor:
Universidad Autonoma de Nuevo Leon
Conditions:
Alopecia Areata
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
The efficacy of two intralesional treatment modalities for alopecia areata will be determined. Thirty patients over the age of 6 with the diagnosis of alopecia areata on the scalp, with an extension o...
Eligibility Criteria
Inclusion
- Diagnosis of alopecia areata
- SALT score of less than 50% extension
- Has not received any topical or systemic treatment in the last month
- Signed informed consent
Exclusion
- Any skin condition on the scalp (infectious, inflammatory or neoplastic) that could modify the clinical of trichoscopic features
- Pregnancy or breast-feeding
- Patients in medications that could cause hair loss as side-effects
Key Trial Info
Start Date :
August 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06564805
Start Date
August 20 2024
End Date
December 31 2025
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario "Dr. José Eleuterio González"
Monterrey, Nuevo León, Mexico, 64460